These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10405396)

  • 1. Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms.
    Vahey M; Nau ME; Barrick S; Cooley JD; Sawyer R; Sleeker AA; Vickerman P; Bloor S; Larder B; Michael NL; Wegner SA
    J Clin Microbiol; 1999 Aug; 37(8):2533-7. PubMed ID: 10405396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay.
    Wilson JW; Bean P; Robins T; Graziano F; Persing DH
    J Clin Microbiol; 2000 Aug; 38(8):3022-8. PubMed ID: 10921971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.
    Servais J; Lambert C; Fontaine E; Plesséria JM; Robert I; Arendt V; Staub T; Schneider F; Hemmer R; Burtonboy G; Schmit JC
    J Clin Microbiol; 2001 Feb; 39(2):454-9. PubMed ID: 11158089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
    Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
    Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine.
    Edelstein RE; Nickerson DA; Tobe VO; Manns-Arcuino LA; Frenkel LM
    J Clin Microbiol; 1998 Feb; 36(2):569-72. PubMed ID: 9466779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
    Cornelissen M; van den Burg R; Zorgdrager F; Lukashov V; Goudsmit J
    J Virol; 1997 Sep; 71(9):6348-58. PubMed ID: 9261352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.
    Quiñones-Mateu ME; Albright JL; Mas A; Soriano V; Arts EJ
    J Virol; 1998 Nov; 72(11):9002-15. PubMed ID: 9765445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes.
    Michael NL; Herman SA; Kwok S; Dreyer K; Wang J; Christopherson C; Spadoro JP; Young KK; Polonis V; McCutchan FE; Carr J; Mascola JR; Jagodzinski LL; Robb ML
    J Clin Microbiol; 1999 Aug; 37(8):2557-63. PubMed ID: 10405401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
    Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
    Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of susceptibility of HIV-1 variants to antiretroviral drugs by genotypic and recombinant virus phenotypic analyses.
    Chang S; Zhuang D; Li J; Liu S; Li H; Han J; Li L; Liu Y; Bao Z; Li T; Song H; Zhang W
    Int J Infect Dis; 2015 Aug; 37():86-92. PubMed ID: 26117343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene.
    Stuyver L; Wyseur A; Rombout A; Louwagie J; Scarcez T; Verhofstede C; Rimland D; Schinazi RF; Rossau R
    Antimicrob Agents Chemother; 1997 Feb; 41(2):284-91. PubMed ID: 9021181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human immunodeficiency virus and AIDS in terms of reverse transcriptase and molecular evolution].
    Doi H
    Nihon Rinsho; 1998 Mar; 56(3):803-12. PubMed ID: 9549376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
    Yalçınkaya T; Köse S
    Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of full length human immunodeficiency virus type 1 (HIV-1) gag sequences in viral recombinants applied to drug susceptibility phenotyping.
    Robinson LH; Gale CV; Kleim JP
    J Virol Methods; 2002 Jul; 104(2):147-60. PubMed ID: 12088824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein.
    Peters S; Muñoz M; Yerly S; Sanchez-Merino V; Lopez-Galindez C; Perrin L; Larder B; Cmarko D; Fakan S; Meylan P; Telenti A
    J Virol; 2001 Oct; 75(20):9644-53. PubMed ID: 11559796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 drug resistance in newly infected individuals.
    Boden D; Hurley A; Zhang L; Cao Y; Guo Y; Jones E; Tsay J; Ip J; Farthing C; Limoli K; Parkin N; Markowitz M
    JAMA; 1999 Sep 22-29; 282(12):1135-41. PubMed ID: 10501116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase.
    Hanna GJ; Johnson VA; Kuritzkes DR; Richman DD; Martinez-Picado J; Sutton L; Hazelwood JD; D'Aquila RT
    J Clin Microbiol; 2000 Jul; 38(7):2715-21. PubMed ID: 10878069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand.
    Carr JK; Salminen MO; Koch C; Gotte D; Artenstein AW; Hegerich PA; St Louis D; Burke DS; McCutchan FE
    J Virol; 1996 Sep; 70(9):5935-43. PubMed ID: 8709215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure.
    Young B; Johnson S; Bahktiari M; Shugarts D; Young RK; Allen M; Ramey RR; Kuritzkes DR
    J Infect Dis; 1998 Nov; 178(5):1497-501. PubMed ID: 9780274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.